Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (1-10 of 372) with videos related to

Pageof 38
Sort By:
Cancer Metastasis Reviews|February 8, 2002
Malignant cells, directors of the malignant process: role of transforming growth factor-betaB A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Molecular targets and cancer therapeutics: discovery, development and clinical validationBeverly A. Teicher
Current Opinion in Oncology|July 16, 2014
Antibody drug conjugatesBeverly A Teicher
Biochemical Pharmacology|March 6, 2012
Searching for molecular targets in sarcomaBeverly A Teicher
Hematology/Oncology Clinics of North America|April 1, 1995
Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxiaB A Teicher
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Use of perfluorochemical emulsions in cancer therapyB A Teicher
Current Opinion in Pharmacology|June 16, 2010
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugsBeverly A Teicher
Advances in Experimental Medicine and Biology|April 6, 2006
Hypoxia, tumor endothelium, and targets for therapyBeverly A Teicher
Biochemical Pharmacology|May 12, 2009
Acute and chronic in vivo therapeutic resistanceBeverly A Teicher
Oncotarget|March 9, 2019
CD248: A therapeutic target in cancer and fibrotic diseasesBeverly A Teicher
Pageof 38

Showing results (1-10 of 372) with videos related to

Sort By:
Pageof 38
Cancer Metastasis Reviews|February 8, 2002
Malignant cells, directors of the malignant process: role of transforming growth factor-betaB A Teicher
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Molecular targets and cancer therapeutics: discovery, development and clinical validationBeverly A. Teicher
Current Opinion in Oncology|July 16, 2014
Antibody drug conjugatesBeverly A Teicher
Biochemical Pharmacology|March 6, 2012
Searching for molecular targets in sarcomaBeverly A Teicher
Hematology/Oncology Clinics of North America|April 1, 1995
Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxiaB A Teicher
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Use of perfluorochemical emulsions in cancer therapyB A Teicher
Current Opinion in Pharmacology|June 16, 2010
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugsBeverly A Teicher
Advances in Experimental Medicine and Biology|April 6, 2006
Hypoxia, tumor endothelium, and targets for therapyBeverly A Teicher
Biochemical Pharmacology|May 12, 2009
Acute and chronic in vivo therapeutic resistanceBeverly A Teicher
Oncotarget|March 9, 2019
CD248: A therapeutic target in cancer and fibrotic diseasesBeverly A Teicher
Pageof 38